Instrument Inactif

Autres langues Progenics Pharmaceuticals, Inc.

Actions

US7431871067

Recherche biotechnologique et médicale

Autres langues

01/03/24	Perspective Therapeutics, Inc. completed the acquisition of Radiopharmaceutical Manufacturing Facility in Somerset, New Jersey from Progenics Pharmaceuticals, Inc.
09/01/24	Perspective Therapeutics, Inc. entered into an asset purchase agreement to acquire Radiopharmaceutical Manufacturing Facility in Somerset, New Jersey from Progenics Pharmaceuticals, Inc. for $8 million.
28/12/20	International Isotopes Inc. Terminates Manufacturing and Supply Agreement with Progenics Pharmaceuticals, Inc
13/11/20	Lantheus Holdings, Inc., Progenics Pharmaceuticals, Inc., and Exini Diagnostics AB Announces U.S. Food and Drug Administration Clearance for Ai-Enabled Automated Bone Scan Index in Prostate Cancer on GE Healthcare’S Xeleris Platform
22/06/20	PROGENICS PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)
22/06/20	Progenics Pharmaceuticals, Inc. Announces Board Changes
22/06/20	Progenics Pharmaceuticals, Inc. Announces Executive Changes
22/06/20	Progenics Pharmaceuticals, Inc. Announces Executive Changes
22/06/20	Progenics Pharmaceuticals, Inc. Appoints Robert J. Marshall Jr. as Treasurer
22/06/20	Progenics Pharmaceuticals : Lantheus Completes Merger with Progenics
22/06/20	Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P Composite 1500
22/06/20	Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P 600
22/06/20	Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P 1000
22/06/20	Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P TMI Index
22/06/20	Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P Global BMI Index
22/06/20	Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P 600 Health Care
22/06/20	Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P Biotechnology Select Industry Index
19/06/20	Lantheus Holdings, Inc. completed the acquisition of Progenics Pharmaceuticals, Inc. from Velan Capital, L.P., Virinder Nohria, LTE Partners, LLC, Terence Cooke, Gérard Ber and others.
17/06/20	PROGENICS PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders (form 8-K)
16/06/20	PROGENICS PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)
16/06/20	Progenics Stockholders Approve Merger with Lantheus
11/06/20	PROGENICS PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8-K)
08/06/20	PROGENICS PHARMACEUTICALS INC : Other Events (form 8-K)
28/05/20	PROGENICS PHARMACEUTICALS INC : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)
28/05/20	WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc.